However, CDH1 was low expressed in TNBC (Figure 1) [36, 37], and CDH1 alteration events were mutually exclusive with high-level alterations (amplification or upregulation) of most of SC-TFs used in this study in breast cancers (Supplementary Table  S2). This evidence concerns the gene CDH1 and breast cancer.